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Summary. Factor V Leiden (FVL)-carrying relatives of
selected patients with venous thromboembolism (VTE)
have much higher venous thrombotic risks than FVL-
carrying relatives of unselected consecutive patients with
VTE. To find an explanation for this, we explored other risk
factors of VTE, in particular the presence of high factor VIII
levels, in a retrospective follow-up study. We assessed levels
of factor VIII, factor LX, fibrinogen, protein C, protein S,
antithrombin, the presence of prothrombin 20210A, and
the occurrence of VTE in 61 first-degree relatives of 12
selected thrombophilic families harbouring FVL, and 183
first-degree relatives of 47 unselected families of FVL
carriers with a first VTE. In all families, FVL appeared to
be an independent risk factor for VTE. Higher thrombosis
incidence rates were found in carriers of both FVL and high
factor VEH levels (> 150 EJ/dl), while high levels of factor
VIII appeared to be an independent thrombotic risk factor
only in selected thrombophilic families. The fraction of
individuals with more than one prothrombotic coagulation
disorder was 10% higher in selected families. These results
and the higher thrombotic risks we found in the thrombo-
philic families favour the hypothesis that other unknown co-
existing genetic defects contribute to thrombophilia.
Keywords: venous thromboembolism, factor V Leiden, high
factor VEn levels, hypercoagulability, coagulation factors.
Numerous acquired and inherited conditions have been
identified äs risk factors for venous thromboembolism,
suggesting that venous thrombosis is a multifactorial
disease. Therefore, combinations of (inherited) risk factors
will more often be found in selected patients with
thrombophilia and their relatives than in unselected
patients with venous thrombosis and their relatives.
We recently demonstrated a much higher thrombotic risk
for carriers of factor V Leiden in selected thrombophilic
families than for carriers in families of unselected patients
(Lensen et al, 2000). It is probable that this is caused by the
presence of additional known and unknown, genetic and/or
acquired risk factors for venous thrombosis in the selected
families. Another explanation is purely stochastic: the
selected families happened to be those that had the most
thrombotic events. The difference is crucial between those
two explanations. While an abundance of events would be
apparent in retrospect for both situations, we would not
predict an increased risk for families that had only
coincidentally experienced a large number of thromboses.
Correspondence: Prof. F. R. Rosendaal, Department of Clinical
Epidemiology, Leiden University Medical Centre, CO-P, PO Box 9600,
2300 RC Leiden, The Netherlands. E-mail: f.r.rosendaal@lumc.nl.
If, on the other hand, the high incidence of thrombosis in
the selected families was caused by the presence of
additional risk factors, we would also expect an increased
risk in prospect.
Factor V Leiden is known to be the most common genetic risk
factor for venous thromboembolism and leads to a sevenfold
increased thrombotic risk (Bertina et al, 1994; Ridker et al,
1995; Rosendaal et al, 1995). In Caucasians, factor V Leiden
is present in about 5% of healthy individuals, in 20% of
unselected consecutive patients with deep vein thrombosis,
and in 50% of probands from thrombophilic families (Bertina
et al, 1994; Rosendaal et al, 1995).
Several studies have described the effect of combinations
of factor V Leiden with other coagulation defects on the risk
on venous thrombosis. All these studies demonstrated a
higher thrombotic risk for the combination of defects than
for the single defect (Koeleman et al, 1994, 1995; Zöller et al,
1995; Beauchamp et al, 1996; van Boven et al, 1996;
Martinelli et al, 1998; Mustafa et al, 1998; Tosetto et al,
1998; Salomon et al, 1999). We therefore hypothesized that
the higher thrombotic tendency in thrombophilic families is
probably explained by the combined presence of two or more
(genetic) risk factors. Obviously, more common risk factors
such äs elevated factor VIII levels, are the most probable
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candidates. Penick et al (1966) described for the first time an
association between thrombophilia and elevated factor VIII
levels. Factor VIII levels exceeding 150 lU/dl are present in
about 11% of healthy individuals and increase the venous
thrombotic risk nearly flvefold compared with levels lower
than 100 lU/dl (Koster et al, 1995a; O'Donnell et al, 1997).
Ten per cent of asymptomatic individuals have factor VIII
levels higher than 175 lU/dl (90th percentile of controls)
versus 19% in symptomatic individuals with a single
thrombotic event and 33% in symptomatic individuals
with recurrences (Kraaijenhagen et al, 2000). Because of
this high prevalence and high thrombotic risk, we focused
on the influence of high factor VIII levels on the occurrence
of venous thrombosis in the families of both selected and
unselected patients with factor V Leiden. We hypothesized
that if the thrombotic risk differed between the two groups
owing to an additional risk factor such äs high factor VIII
levels, we would observe, first, an excess of individuals with
high factor VIII levels in (selected) thrombophilic families
compared with unselected families; second, when the two
risk factors, i.e. factor V Leiden and high factor VIII levels,
are taken into account, the difference in risk between
selected and unselected families should largely disappear.
PATIENTS AND METHODS
Patients and families. We included 61 first-degree relatives
(siblings, parents and children of the proband) of 12 selected
thrombophilic families with factor V Leiden (i.e. referred to
our centre for diagnostic work-up for venous thrombophilia
because there were at least two symptomatic relatives in
addition to the proband). There were 32 men and 29 women,
the median age was 47 years (ränge, 23-70 years). We
contrasted these first-degree relatives with 183 first-degree
relatives of 47 unselected factor V Leiden carriers from a
consecutive series with a first venous thrombosis. In this
group were 80 men and 103 women, and the median age
was 49 years (ränge, 16-70 years). Approximately half the
relatives in both groups were carriers of factor V Leiden. One
citrated blood sample was obtained from all individuals. A
standardized history was taken on the occurrence of venous
thromboembolism before screening for the factor V Leiden
mutation took place. Venous thrombotic events (excluding
superficial thrombophlebitis) were those that were diagnosed
by physicians (70% were objectively diagnosed: ultrasound,
venography, pulmonary angiography or lung Ventilation
perfusion scan; 30% were diagnosed on clinical observation
only). Blood was collected in a 1/10 volume of 0-106 mol/1
sodium citrate and centrifuged for 10 min at 2000 g. Plasma
was stored at — 70°C. All laboratory assays were carried out
by technicians unaware of the patient medical history. As
expected, some (four) of the 47 unselected families also met
the criteria set for the selection of the thrombophilic families.
In the analysis, these families (21 relatives) were regarded äs
part of the panel of unselected families unless stated
otherwise.
Detection of coagulation defects. The mutation of the factor
V gene was detected äs described previously (Bertina et al,
1994). Factor VIII:Ag was measured in triplicate using a
sandwich-type enzyme-linked immunosorbent assay
(ELISA) äs previously described, using two monoclonal
antibodies directed against different epitopes on the light
chain of factor VIII (CLB CAgA and CLB CAgll7). These
monoclonal antibodies were kindly provided by Dr J. van
Mourik (Department of Blood Coagulation, CLB, Sanguin
Blood Supply Foundation, Amsterdam, The Netherlands).
The intra- and interassay coefficients of Variation were 4-3
and 5-6 respectively. Pooled normal plasma, calibrated
against the World Health Organization (WHO) Standard
(91/666) for von Willebrand factor (VWF):Ag, factor VIII:C
and factor VIILAg, was used äs a reference. We used a factor
VIII level of 150 lU/dl äs the cut-off point; the same cut-off
level had been used previously in the analysis of the Leiden
Thrombophilia Study (Koster et al, 1995a). Factor IX
antigen levels were also determined using ELISA (van
Hylckama Vlieg et al, 2000). Fibrinogen concentration was
determined according to the method of Clauss using the
DadeR thrombin reagent (Baxter, Miami, USA). The
prothrombin genes were analysed for the 20210A mutation
using polymerase chain reaction and Hindlll digestion äs
described before (Poort et al, 1996). All individuals were
screened for deficiencies of protein C, protein S and
antithrombin; no deficiencies were found.
Statistics. Incidence rates in different groups were
calculated by dividing the number of first events by the
total of observation-years (follow-up time). Follow-up
started at birth and ended at the date of the interview or
the date of the first thrombotic event, whichever came first.
We constructed thrombosis-free survival curves using the
Kaplan-Meier method. We used Cox regression analysis to
study the role of the genetic risk factors: heterozygosity for
factor V Leiden and the presence of high levels of factor VIII.
In a separate Cox regression analysis including all relatives
of both groups of families, we also entered the 'group of
family' (selected thrombophilic families versus families of
unselected consecutive patients) to which the relative
belonged äs a risk factor in the model (excluding propositi).
We investigated interaction under an additive model
between factor V Leiden and the presence of high levels of
factor VIII in the two groups by comparing the incidence
rate for carriers of both disorders with the sum of the
incidence rates found in carriers of only factor V Leiden or
elevated factor VIII levels. We also investigated interaction
under a multiplicative model between the two disorders by
comparing the relative risk for carriers of both defects with
the product of the relative risks found in carriers of one of
the two disorders. As main determinants of risk, we
investigated factor V Leiden and factor VIII levels. Fibrino-
gen levels, factor IX levels and the 20210 G to A
prothrombin variant were entered äs covariates in some of
our models.
RESULTS
Selected thrombophilic families with factor V Leiden
We investigated 61 first-degree family members of the 12
probands from thrombophilic families. The overall incidence
rate of venous thrombosis was 0-7%/year (18 events in
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Table I. Data on thrombotic tendencies in relatives of symptomatic propositi äs represented by mcidence rates accordmg to family type and
prothrombotic coagulation disorder*
Factor V Leiden +
Factor V Leiden —
Factor Vlla 150 lU/dl























"Tncidence rates are in percentage/year There was no plasma available m four relatives of selected families and m 13 relative of unselected
families
2544 person-years) Of the 61 relatives, 32 carned factor V
Leiden and 15 (47%) of these carners had experienced a
thrombotic event (mcidence rate l 2%/year, Table I) Ofthe
29 non-carners, three (10%) had experienced a venous
thrombosis (mcidence rate 0 2%/year) Therefore, the rate
ratio of factor V Leiden for venous thrombosis was 5 l (95%
CI l 5-16 4)
Unselected families with factor V Leiden
We investigated 183 first-degree relatives of 47 unselected
consecutive patients factor V Leiden and a first venous
thrombosis The overall mcidence rate of venous thrombosis
was 0 16%/year (13 events m 8293 person-years), i e four
times lower than m the thrombophilic families Of these 183
relatives, 101 carned factor V Leiden and mne (9%) had
experienced a thrombotic event (mcidence rate 0 20%/
year) Of the 82 non-carners, four (5%) had experienced a
venous thrombosis (mcidence rate 0 11%/year), also lower
than m the thrombophilic families Here, the rate ratio of
factor V Leiden for venous thrombosis was l 8 (95% CI
0 6-6 0)
High factor VIII levels
In the selected thrombophilic families with factor V Leiden,
high factor VIII levels were found in 33% of the relatives Of
these relatives with high factor VIII levels, 59% had
experienced a thrombotic event As Table I shows, high
factor VIII levels were associated with a threefold mcreased
nsk of thrombosis in these families (m those with factor VIII
levels > 150 lU/dl l 19%/year versus 0 39%/year m those
with factor VIH levels <150IU/dl) In families of the
unselected patients with factor V Leiden, high factor VIII
levels were found m 42% of the relatives Of these relatives
with high factor VIII levels, 11% had experienced a
thrombotic event In these families the thrombotic nsk in
mdividuals with high factor VIII levels was somewhat
higher (0 18%/year) than in mdividuals with factor VIII
levels < 150 lU/dl (0 14%/year) So, we found a high
prevalence of high factor VIII levels m thrombophilic
families and unselected families, but no sigmficant differ-
ence m the prevalence of high factor VIII levels between the
two groups [after exclusion of the four unselected families
who met the critena set for the selection of thrombophilic
families (unselected thrombophilic families), but the throm-
botic mcidence in mdividuals with high factor VIII levels
was 0 13%/year versus 0 05%/year m mdividuals with
factor VIII levels < 150 ITJ/dl]
Fflttor V Leiden combmed with the presence of high factor VIII
levels
We explored the effect on the thrombotic mcidence of high
factor VIII levels m relation to factor V Leiden Table II
shows the mcidence rates for factor V Leiden and the
presence of high factor VIII levels In both thrombophilic
families and unselected families, relatives with the combma-
tion of factor V Leiden and high factor VIII levels had an
mcreased mcidence rate of venous thrombosis compared
with family members with only high factor VIII levels or
only factor V Leiden The thrombotic mcidence, whenever
one or two of these factors were present, was mvanably
higher m thrombophilic families than m unselected families
Lowest mcidence rates were found m relatives without
factor V Leiden but with high factor VIII levels in the
unselected families
When we excluded the four unselected thrombophilic
families, the thrombotic mcidence in unselected families m
mdividuals without factor V Leiden or high factor VILT levels
decreased from 0 12%/year (Table II) to 0 06%/year, more
than 50% lower than the mcidence found m thrombophilic
families (0 13%/year)
To determme the contnbution to nsk of these risk factors
(i e factor V Leiden and high factor VIII levels) in both
settmgs, we calculated rate ratios for relatives (no propositi)
of selected thrombophilic families by application of a Cox
regression model (Table ΠΙΑ) We included the 20210 G to
A prothrombm variant, the presence of fibnnogen levels
higher than 4 g/l and the presence of factor IX levels higher
than 129 U/dl äs additional risk factors for more precise
estimations In Table IIIB, the rate ratlos are presented for
the unselected families (there were too few mdividuals to
estimate the rate ratio for the 20210 G to A prothrombm
variant) For the data shown m Table IIIC, i e to study the
effect of being a member of a thrombophilic family, we added
the four unselected thrombophilic families to the panel of
selected thrombophilic families The strengest risk factor
was kmship to thrombophilic families (rate ratio 9 1)
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Table II. Incidence rates of venous thrombosis m relatives of symptomaüc propositi m the absence or presence of factor V Leiden without and
with the high factor VIII levels according to famüy type
*Reference category
FVL factor V Leiden FVIII>
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high factor VIII levels Incidence rates are m percentage per years
Table III. Adjusted rate ratios (95% CI) for the mam potential nsk
factors on venous thrombotic events
(A) For relatives (no propositi) of thrombophilic families *
Potential nsk factor Rate ratio (95% CI)
Factor V Leiden
High factor VIII levels
20210 G to A prothrombm vanant
High fibrinogen levels
High factor IX levels
6 2 (95% CI l 6-24 5)
3 9 (95% CI l 2-12 9)
4 8 (95% CI 0 8-29 6)
l 4 (95% CI 0 2-8 0)
l 0 (95% CI 0 3-3 3)
(B) For relatives (no propositi) of unselected families
Potential nsk factor Rate ratio (95% CI)
Factor V Leiden
High factor IX levels
High factor VIII levels
High fibrinogen levels
2 2 (95% CI 0 6-7 2)
2 l (95% CI 0 7-6 6)
l 2 (95% CI 0 4-3 9)
0 3 (95% CI 0 1-2 7)
(C) For all (246) relatives (no propositi) from both famüy panels
Potential risk factor Rate raho (95% CI)
Relationship to thrombophilia families
Factor V Leiden
High factor VIII levels
20210 G to A prothrombm vanant
High factor IX levels
High fibrinogen levels
9 l (95% CI 3 6-23 2)
3 4 (95% CI l 4-8 2)
2 8 (95% CI l 3-6 4)
3 9 (95% CI 0 8-18 9)
l 2 (95% CI 0 5-2 6)
0 9 (95% CI 0 2-3 4)
*The rate ratios are the nsks of thrombosis m the presence of the
nsk factor compared with its absence adjusted for the other factors
m the model All variables are coded äs yes/no For (C) we mcluded
the four famüies from the unselected patients fulfdlmg the cnteria
for thrombophilic families among the thrombophilia families
followed by the 20210 G to A prothrombm vanant (rate
ratio 3 9 Table IIIC) and factor V Leiden (rate ratio 3 4)
Table IV shows a summary of the effect of the presence,
respectively, of none and one or more coagulation disorders
m selected and unselected families An mcrease of mcidence
rate of venous thrombosis with a higher number of
coagulation disorders is found in relatives of both selected
thrombophilic families and unselected families
Figure 1A and B show the thrombosis-free survival for
affected and non-affected relatives with factor V Leiden and/
or high factor VIII levels m selected thrombophdic families
and unselected families respectively In selected thrombo-
philic families, the probability of still bemg free of venous
thrombosis m carners of both defects was 75% at age
27 years, while in families of unselected propositi this was
the case at the age of 5 5 years
DISCUSSION
In order to explam the different venous thrombotic nsks in
first-degree relatives of probands of selected thrombophilic
families and first-degree relatives of unselected patients with
thrombosis, we screened for genetic and other common risk
factors for thrombosis and analysed their contnbution to the
thrombotic nsk m families of 12 highly selected thrombo-
philic patients with factor V Leiden and m families of 47
unselected consecutive patients with factor V Leiden In
both groups, factor V Leiden carriership was an independent
risk factor, while high factor VIII levels appeared to be an
independent risk factor only in selected thrombophilic
families (and in unselected families after exclusion of the
four unselected thrombophilic families) Highest incidences
were found in carners of both defects in both selected and
unselected families However, individuals with factor V
Leiden or high factor VIII levels m thrombophilic families
had a fourfold higher thrombotic mcidence rate than
mdividuals with the same abnormaliües in families of
unselected probands Although this difference between the
two types of families remamed m multivariate analysis, this
difference in thrombotic risk largely disappeared when
individuals with neither abnormality were compared
Despite the high mcidence rates in the selected families
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Table IV. Incidence rates of venous thrombosis m relatives of symptomatic propositi m the absence or presence of one or more prothrombotic
coagulation defects accordmg to famdy type

























































Incidence rates are m percentage/year Relatives from whom one or more defects could not have been detected were excluded (four relatives
from the selected famihes and 13 relatives from unselected famihes)
and the wide confidence mtervals, mteraction between
factor V Leiden and high factor VIII levels appeared to be
present m selected famihes (mteraction under an additive
and multiplicative model) The mcidence rate m carriers of
both defects m selected farmlies was eight times (95% CI
2 7-22 7) the mcidence rate m carriers of both defects m
unselected famüies The presence of high factor VIII levels
appeared to increase the thrombotic mcidence three times
(95% CI l 1-9 8) m factor V Leiden carriers of selected
famihes and nearly twofold (95% CI 0 5-6 7) m factor V
Leiden carriers of unselected famihes compared with
carriers of factor V Leiden only
In the most fully adjusted model, 'family type' remams the
strengest predictor, while m umvanate analysis, nsks are
higher m selected famihes whenever either factor V Leiden
or high factor VIII levels are present (Table II) The only
logical explanation seems to be the presence of at least one
more genetic risk factor, which has only a mild effect m
itself, but that has a synergistic effect with other risk factors
such äs factor V Leiden and high levels of factor VIII As
deficiencies of protein C, protein S and antithrombm were
not present m these famihes, and äs we took into account
fibnnogen levels, factor IX levels and the 20210 G to A
prothrombin vanant, other unknown genetic risk factors
are probably responsible for the difference of thrombotic risk
m the two differently selected family panels
One of our initial hypotheses was that the thrombotic
tendency m thrombophilic famihes is higher than m
unselected famihes because of clustenng of prothrombotic
coagulation defects in thrombophilic famihes This hypoth-
esis was partly conflrmed we did not find a higher
frequency of prothrombotic coagulation abnormahties in
relatives of selected patients with factor V Leiden (80%) than
m unselected famihes with factor V Leiden (86%) On the
other hand, we found that combinations of prothrombotic
coagulation disorders (49%) were shghtly more often found
A 10 B 10
Age (years) Age (years)
Fig 1. (A) Thrombosis-free survival curves m non affected relatives (0) in relatives with only high factor VIII levels (1) m relatives with only
factor V Leiden (2) and m relatives with both defects(3) of selected thrombophiha famihes with factor V Leiden (B) Thrombosis-free survival
curves m non-affected relatives (0) in relatives with only high factor VIII levels (1) m relatives with only factor V Leiden (2) and m relatives
with both defects (3) of unselected consecutive patients with factor V Leiden
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m thrombophihc famihes than m unselected famihes (39%)
Also, the fraction of faimlies harbounng the 20210 G to A
prothrombm vanant was higher in thrombophilic famihes
(2/12, 17%) than m unselected famihes (2/47, 4%). The
idea that co-existing coagulation defects cause a higher
thrombotic tendency was well illustrated by the mcreasmg
mcidence rate m individuals with a combmation of more
coagulation disorders
It is still unclear whether high factor VIII levels are
caused by genetic or environmental mechamsms, apart
from the genetic blood group effect. Results from other
studies suggest that factor VIII levels are at least in part
genetically determmed (Kamphuisen et al, 1998). Both in
thrombophilic famihes and unselected famihes, higher
percentages of individuals with high factor VIII levels were
found than m the general population
We compared factor VIII levels s 150 lU/dl with factor
VIII levels < 150 lU/dl, while in our previous case-control
(Leiden Thrombophiha Study, LETS) study we compared
factor VIII levels >150IU/dl with factor VIII levels
< 100 lü/dl (Koster et al, 1995a). This is responsible for
the lower rate ratios in this study (see Table III) When
companng levels > 150 lU/dl with levels < 150 lU/dl m the
same LETS data, a lower relative nsk of 2 65 (95% CI l 7-
4-1) is also found The synergistic effect between factor V
Leiden and high factor VIII levels previously observed in a
case-control study (LETS) was confirmed by the results of
the present family studies (Koster et al, 1995b)
A hmitation of the present study is the fact that one third
of the thrombotic events were not objectively diagnosed.
This may cause a small overestimation of the rate ratios:
after exclusion of the non-objectified thrombotic events, we
found shghtly lower rate ratios (but with wider confidence
intervals).
In conclusion, elevated factor VIII levels are a moderate
determmant of thrombotic nsk, while the combmed
presence of factor VIII levels >150IU/dl with factor V
Leiden appeared to be a strong determmant of thrombotic
risk, particularly in selected famihes with thrombophiha.
The higher nsks found m thrombophilic famihes suggest the
presence of other unknown genetic nsk factors in these
famihes.
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